341 related articles for article (PubMed ID: 26536229)
1. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
2. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release.
Skovdahl HK; Damås JK; Granlund AVB; Østvik AE; Doseth B; Bruland T; Mollnes TE; Sandvik AK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347808
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
[TBL] [Abstract][Full Text] [Related]
4. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.
Østvik AE; Granlund AV; Torp SH; Flatberg A; Beisvåg V; Waldum HL; Flo TH; Espevik T; Damås JK; Sandvik AK
Clin Exp Immunol; 2013 Sep; 173(3):502-11. PubMed ID: 23668802
[TBL] [Abstract][Full Text] [Related]
5. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation.
Hanna DN; Smith PM; Novitskiy SV; Washington MK; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Zhu J; Yang J; Liu Q; Beauchamp RD; Means AL
Gastroenterology; 2022 Nov; 163(5):1334-1350.e14. PubMed ID: 35863523
[TBL] [Abstract][Full Text] [Related]
6. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
[TBL] [Abstract][Full Text] [Related]
7. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
[TBL] [Abstract][Full Text] [Related]
8. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CCL20 in human inflammatory bowel disease.
Kaser A; Ludwiczek O; Holzmann S; Moschen AR; Weiss G; Enrich B; Graziadei I; Dunzendorfer S; Wiedermann CJ; Mürzl E; Grasl E; Jasarevic Z; Romani N; Offner FA; Tilg H
J Clin Immunol; 2004 Jan; 24(1):74-85. PubMed ID: 14997037
[TBL] [Abstract][Full Text] [Related]
10. In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.
Ohtani H; Nakayama T; Yoshie O
Pathol Int; 2011 Nov; 61(11):645-51. PubMed ID: 22029675
[TBL] [Abstract][Full Text] [Related]
11. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
[TBL] [Abstract][Full Text] [Related]
13. Expression of the chemokine receptor CCR6 in human renal inflammation.
Welsh-Bacic D; Lindenmeyer M; Cohen CD; Draganovici D; Mandelbaum J; Edenhofer I; Ziegler U; Regele H; Wüthrich RP; Segerer S
Nephrol Dial Transplant; 2011 Apr; 26(4):1211-20. PubMed ID: 20844183
[TBL] [Abstract][Full Text] [Related]
14. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease.
Kwon JH; Keates S; Bassani L; Mayer LF; Keates AC
Gut; 2002 Dec; 51(6):818-26. PubMed ID: 12427784
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
16. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
[TBL] [Abstract][Full Text] [Related]
17. CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues.
Zhang W; Nie L; Wang Y; Wang XP; Zhao H; Dongol S; Maharjan S; Cheng L
PLoS One; 2013; 8(6):e66286. PubMed ID: 23823618
[TBL] [Abstract][Full Text] [Related]
18. Expression of CCR6 and CXCR6 by Gut-Derived CD4
Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
[TBL] [Abstract][Full Text] [Related]
19. Chemokines as novel therapeutic targets for inflammatory bowel disease.
Nishimura M; Kuboi Y; Muramoto K; Kawano T; Imai T
Ann N Y Acad Sci; 2009 Sep; 1173():350-6. PubMed ID: 19758172
[TBL] [Abstract][Full Text] [Related]
20. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
